Full-Time

Clinical Services Manager

Posted on 1/14/2025

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Compensation Overview

$130k - $160kAnnually

Mid

Portsmouth, NH, USA + 2 more

More locations: Bangor, ME, USA | Portland, ME, USA

The position requires regular business travel mostly by car within a set geographic region, including Bangor, ME, and Portsmouth, NH.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Salesforce
Requirements
  • Excellent communication skills, both oral and written
  • Strong influencing and collaboration skills with the ability to build and nurture relationships
  • Demonstrated skill educating in a clinical setting (both providers and patients)
  • Team-oriented with proven ability to work in a collaborative setting
  • Ability to solve complex problems and take appropriate action
  • Ability to execute territory business strategy
  • Proficiency with technology (both large data systems as well as personal devices, such as insulin pumps and continuous glucose monitors)
Responsibilities
  • Build strong relationships with key stakeholders, including endocrinologists, primary care providers, and diabetes management teams in hospitals, clinics, and private practices
  • Share your expertise with healthcare providers about diabetes management, including the latest technologies and best treatment practices to ensure consistent, high-quality care to patients
  • Expand your network and credibility within the diabetes community by actively participating in local events and initiatives that position you as a leader in diabetes care
  • Schedule and deliver personalized training to patients on the proper use and care of Insulet products, ensuring they feel confident and informed about their treatment
  • Assess patient needs and customize training programs, tailoring sessions to accommodate varying levels of familiarity with the device
  • Provide ongoing support and education, offering follow-up consultation to address questions, troubleshoot issues, and ensure successful long-term device usage
  • Collaborate with healthcare providers to ensure training aligns with clinical treatment plans, fostering seamless integration of the device into the patient’s care routine
  • Empower patients to manage their condition effectively by explaining device features, functionality, and best practices for optimal results in everyday use
  • Evaluate and recommend Certified Pod Trainers (CPTs) who wish to become consultant CPTs for Insulet
  • Oversee CPTs by providing timely product updates and being a clinical resource
  • Leverage multiple data sources to inform education strategy and individual/team actions
  • Maintain and update data systems, such as Salesforce, to capture training metrics
  • Conduct administrative responsibilities, managing operations while adhering to budgetary guidelines
  • Empower decision-making by promoting the life-changing benefits of insulin pump therapy to healthcare providers and patients
  • Collaborate closely with territory partners to achieve shared sales goals while contributing your clinical expertise to shape effective strategies
  • Champion inspiring patient success stories, leveraging real-world examples to demonstrate the impact of Insulet’s solutions and drive product adoption through clinical selling techniques
  • Execute field sales activities with a strategic, patient-centered approach, ensuring all promotional efforts are aligned with established guidelines while maximizing impact in the field
Desired Qualifications
  • Bachelor’s degree (strongly preferred) and with 2+ years’ related experience. Associate degree (minimally required)
  • Professional, up-to-date credentials and/or certifications (required: Certified Diabetes Educator (CDE), Registered Dietitian (RD), or Registered Nurse (RN); state licensure (as required per state); Certified Diabetes Educator (CDE) (strongly preferred)
  • Minimum of 2 years’ experience conducting training in a clinical setting and/or managing insulin pump patients (preferred)
  • Prior industry/commercial experience (preferred)

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Insulet won $452 million in a trade secrets trial against EOFlow.
  • Omnipod 5 expansion in Europe increases market reach and potential revenue.
  • New Malaysian facility supports production scale-up and job creation.

What critics are saying

  • Regulatory challenges may hinder Omnipod 5's European market expansion.
  • Legal battles from the EOFlow case could affect Insulet's financial stability.
  • Geopolitical risks in Malaysia may impact the new facility's operations.

What makes Insulet Corporation unique

  • Insulet's Omnipod 5 integrates with Dexcom G7 CGM, enhancing diabetes management.
  • Insulet is a leader in tubeless insulin pump technology with its Omnipod brand.
  • Omnipod 5's iPhone app availability boosts accessibility for U.S. users.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Financial Modeling Prep
Mar 6th, 2025
Ubiquiti Inc. (NYSE:UI) Outshines Peers in Capital Efficiency

Ubiquiti competes with companies like Fair Isaac Corporation, Paylocity Holding Corporation, Monolithic Power Systems, EPAM Systems, and Insulet Corporation.

MPO Magazine
Jan 14th, 2025
Insulet Rolls Out Omnipod 5 in Five More European Countries

Also in June 2024, Insulet launched Omnipod 5 with the Dexcom G7 CGM.

Bloomberg Law
Dec 5th, 2024
Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial

EOFlow Co. Ltd. must pay Insulet Corp. $452 million for stealing trade secrets related to its insulin pumps, a Massachusetts federal jury ruled.

MPO Magazine
Dec 5th, 2024
Insulet Wins $452 Million Trade Secret Victory Against EOFlow

Insulet was awarded $170 million in compensatory damages from EOFlow and a further $282 million in exemplary damages for willful and malicious misappropriation.

Stock Titan
Oct 29th, 2024
Omnipod(R) 5 App for iPhone(R) Now Fully Available in the United States

ACTON, Mass.-(BUSINESS WIRE)- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, today announced the full market release of the Omnipod 5 App for iPhone(R) in the U.S.

INACTIVE